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Matrix-assisted laser desorption/ionization time-of-
flight (MALDI-TOF) mass spectrometry (MS) offers the
possibility of accurate, rapid, inexpensive identifica-
tion of bacteria, fungi, and mycobacteria isolated in
clinical microbiology laboratories. The procedures
for preanalytic processing of organisms and analysis
by MALDI-TOF MS are technically simple and repro-
ducible, and commercial databases and interpretive
algorithms are available for the identification of a
wide spectrum of clinically significant organisms. Al-
though only limited work has been reported on the
use of this technique to identify molds, perform
strain typing, or determine antibiotic susceptibility
results, these are fruitful areas of promising research.
As experience is gained with MALDI-TOF MS, it is
expected that the databases will be expanded to re-
solve many of the current inadequate identifications
(eg, no identification, genus-level identification) and
algorithms for potential misidentification will be de-
veloped. The current lack of Food and Drug Adminis-
tration approval of any MALDI-TOF MS system for
organism identification limits widespread use in the
United States. (J Mol Diagn 2012, 14:419–423; http://dx.
doi.org/10.1016/j.jmoldx.2012.03.007)
It is rare that a technology can fundamentally alter well-
established diagnostic testing methods, but that is pre-
cisely what the use of matrix-assisted laser desorption/
ionization time-of-flight (MALDI-TOF) mass spectrometry
(MS) has done in Europe, where it is widely used for
identification of bacteria, mycobacteria, and fungi. For
100 years, microbes were characterized by their bio-chemical properties, that is, the ability of organisms to
use various substrates for growth and metabolic activity.
As discovery of new organisms rapidly expanded the
need for more complex identification algorithms, a prolif-
eration of reference books1–3 documenting detailed iden-
tification tables for each family of organisms and the use
of sophisticated commercial identification systems prolif-
erated. In the last 20 years the use of gene sequencing
techniques that targeted ribosomal RNA genes and var-
ious housekeeping genes permitted more precise iden-
tification of organisms but at significant technical and
financial costs. These techniques are not practical for
routine identification of organisms; however, they are
useful for identification of uncommonly isolated bacteria
and fungi. Indeed, the combination of gene sequencing
and biochemical tests has proven valuable for the pre-
cise identification of organisms used for constructing da-
tabases for MALDI-TOF MS.
Mass Spectrometry in Biomarker Detection
In 1975, Anhalt and Fenselau4 described the use of bio-
markers detected by mass spectrometry for the identifi-
cation of bacteria. Despite the promise of this work and
the development of significant advances in specimen
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formatics during the next 25 years, adoption of this tech-
nology by clinical laboratories occurred slowly. Early
studies targeted the analysis of polar fatty acids that
comprised 5% to 8% of the dry cell weight of bacteria,
whereas more recent studies focused on analysis of ba-
sic proteins, primarily in the range of 2000 to 20,000 Da
(60% to 70% of the dry cell weight of bacteria). In 1994,
Cain et al5 reported that MALDI-TOF MS could be used to
differentiate selected bacteria by analysis of protein pro-
files from disrupted cells. Two years later, Claydon et al,6
Holland et al,7 and Krishnamurthy et al8 demonstrated
the feasibility of processing intact bacterial cells. This
work was extended to eukaryotic cells in 2000 and 2001,
when investigators reported that whole fungal cells could
also be identified using MALDI-TOF MS.9–11 Subsequent
work, primarily from research laboratories, demonstrated
that individual species of bacteria and fungi could be
accurately identified by MALDI-TOF MS at the species or
subspecies level; however, the versatility of the technol-
ogy to identify the wide spectrum of bacteria, yeasts,
molds, and mycobacteria that can be isolated in clinical
specimens was only recently demonstrated.12–18
The method as initially introduced is technically simple
and rapid. Bacterial colonies are removed from agar cul-
ture plates, mixed with an excess of UV-absorbing matrix,
and dried on steel target plates. The dried preparations
are exposed to laser pulses, resulting in energy transfer
from the matrix to the nonvolatile analyte molecules, with
desorption (removal) of analyte into the gas phase. The
ionized molecules are accelerated by electric potentials
through a flight tube to the mass spectrometer, with sep-
aration of the biomarkers determined by their mass/
charge ratio (m/z; z typically is 1). The profile of biomark-
ers is then compared with profiles of a collection of well-
characterized organisms (Figure 1).
An Overview of MALDI-TOF MS
Critical for the successful use of MALDI-TOF MS in clin-
ical laboratories is the demonstration that the method isFigure 1. MALDI-TOF MS for microorganism identification.reproducible and highly discriminatory. The preanalysis
preparation of the sample for MALDI-TOF MS is critical
for reproducible spectral profiles and test sensitivity.19
Bacteria or yeast can be selected from a culture plate or
concentrated from broth cultures and either transferred
directly to a target plate or pretreated with ethanol fol-
lowed by protein extraction with formic acid and aceto-
nitrile. Pretreatment is beneficial because it inactivates
the organisms, enhances detection of biomarkers above
15 kDa, and improves sample stability.20 Although pre-
treatment can be omitted for analysis of most bacteria, it
is necessary for the generation of yeast spectral profiles
and yields higher spectral scores for all bacteria.18,21
Before analysis by MALDI-TOF MS, optimum sensitivity
requires disruption of the cell wall structure by treating
the cells with a strong organic acid (eg, formic, trifluoro-
acetic, and acetic) either before or concurrent with the
addition of the matrix solution. Selection of the matrix
influences the specific biomarkers that are detected (eg,
proteins, phospholipids, and cyclic lipopeptides), with
-cyano-4-hydroxy-cinnamic acid used preferentially for
detection of protein biomarkers.7 Thus, although a variety
of sample preparation methods have been evaluated, a
relatively uniform approach has evolved for the identifi-
cation of bacteria and yeast from cultured specimens.22
Sample Preparation
Single colonies are selected and suspended in a small
volume of 70% ethanol (microbial inactivation), briefly
vortexed, and then concentrated by centrifugation. The
supernatant is discarded and the cells are resuspended
in 50 L of 70% formic acid (cell wall disruption), an
equal volume of acetonitrile is added (protein extraction),
the sample is vortexed, and it is again concentrated by
centrifugation. One microliter of the supernatant with the
extracted proteins is spotted on the target plate, allowed
to evaporate to near dryness, and then overlaid with the
matrix consisting of a saturated solution of -cyano-4-
hydroxy-cinnamic acid in 50% acetonitrile and 2.5% trif-
luoroacetic acid. With this protocol, sufficient spectra are
obtained for organism identification if the initial solution
contains a minimum of 5 to 10  106 cells/mL.23,24 Most
work in clinical laboratories is performed on isolated col-
onies grown on nutrient agar plates, so the presence of
sufficient numbers of cells in a sample is not a limitation.
Until recently, samples were spotted onto stainless steel
plates, but Schuerenberg et al25 demonstrated that coat-
ing predetermined spots on steel plates (anchors) with a
thin layer of polytetrafluoroethylene (Teflon) allowed the
sample/matrix to concentrate on the anchor spot during
solvent evaporation, resulting in more homogenous crys-
tallization of the matrix and excellent biomarker spectra
reproducibility. As a practical matter, using these plates
makes sample spotting technically easier to perform
manually and reduces the risk of cross-contamination of
samples due to spreading of a sample into an adjacent
spot. Commercially prepared, disposable sample plat-
forms have also been developed for clinical laboratories,
but there is little need for this because the target plates
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Biomarker Detection
Most biomarkers detected in MALDI spectra are intracel-
lular proteins primarily in the range of 4000 to 15,000
Da.26 Lysis of organisms with organic solvents in acidic
conditions favors extraction of basic cytoplasmic pro-
teins, specifically ribosomal and mitochondrial proteins,
cold shock proteins, heat shock proteins, DNA binding
proteins, and RNA chaperone proteins.11,27 These are
highly conserved housekeeping proteins and serve as
ideal biomarkers for characterizing individual species.
Bacteria
A number of published studies have demonstrated the
accuracy of MALDI-TOF MS for the identification of a
broad spectrum of bacteria,12,14–16,28–33 including gram-
positive cocci and rods, fermentative and nonfermenta-
tive gram-negative rods, and anaerobes. In general,
90% of all isolates are identified at the species level,
98% are identified at the genus level, and 1% are in-
correctly identified. The most common reason an isolate
is not identified is because it is not included in the data-
base. For example, Justesen et al30 and Velloo et al33
reported 67% of anaerobes could be identified with the
Bruker microflex MS systems (Billerica, MA). In contrast,
Fedorko et al32 reported 86% of anaerobes were iden-
tified with the Bruker microflex system when an expanded
database was used. Misidentifications are most com-
monly observed with taxonomically related bacteria, such
as Shigella with Escherichia and Streptococcus pneu-
moniae with S. mitis. As experience is gained with MALDI-
TOF MS, it is expected that the database will be ex-
panded to resolve many of the current inadequate
identifications (eg, no identification, genus-level identifi-
cation) and algorithms for potential misidentification will
be developed (eg, rapid bile solubility test to confirm a S.
pneumoniae identification).
Yeast
Identification of yeasts isolated in culture can also be
performed accurately,13,18,34,35 including differentiation
of closely related species (eg, Candida albicans and C.
dubliniensis; C. guilliermondii and C. kefyr; C. metapsilosis,
C. orthopsilosis, and C. parapsilosis). More limited studies
have been performed with filamentous fungi, primarily
because routine identification is based on morphologic
features; however, preliminary studies have demon-
strated that Aspergillus, Fusarium, and Penicillium can be
identified accurately at the species level.36–38
Organisms in Blood Culture Broths
A number of studies have demonstrated the usefulness of
MALDI-TOF MS for identification of bacteria and yeastsisolated in blood culture broths.39–45 Processing these
specimens is more complex because the nonmicrobial
cells, serum proteins, and broth culture nutrients must be
removed before the microbial cells are evaluated. How-
ever, definitive identification results from positive blood
culture broths are generally available in 1 hour. Al-
though, approximately 15% to 20% of the isolates are not
initially identified, primarily because insufficient numbers
of cells are available, modification of the extraction pro-
cedures has improved the test sensitivity.46,47 However,
not all blood culture broth formulations produce ade-
quate results, particularly media supplemented with
charcoal.48–50
Mycobacteria
Identification of mycobacteria and other acid-fast organ-
isms by MALDI-TOF MS poses a particular challenge
because the organisms must be sacrificed before pro-
cessing for safety reasons and cell lysis using methods
developed for other microorganisms is inadequate.
Saleeb et al51 resolved these problems by heating the
bacterial suspension for 30 minutes at 95°C to sacrifice
the mycobacteria, dispersing the bacteria using a mi-
cropestle, and lysing the organisms by vortexing the sus-
pension with glass beads in the presence of formic acid
and acetonitrile. They demonstrated that virtually all spe-
cies of mycobacteria could be identified with a 90-minute
turnaround time, significantly faster than the days to
weeks that were required for identification by gene se-
quencing or biochemical tests.
Microbial Typing and Antimicrobial
Susceptibility Testing
In addition to microbial identification, MALDI-TOF MS has
been applied to two other areas: microbial typing and
antimicrobial susceptibility testing. Because MALDI-TOF
MS detects a large spectrum of proteins, the technique
should be able to discriminate between closely related
species and to classify organisms at the subspecies
level. Work with virtually all genera of bacteria and many
fungal isolates has demonstrated MALDI-TOF MS as a
feasible approach for subspecies classification.52 How-
ever, only limited work has been performed demonstrat-
ing that the spectral profiles are reproducible and dis-
criminating for strain typing and that results are
comparable to conventional typing methods, such as
pulsed-field gel electrophoresis. If future studies prove
this is a viable technique, then MALDI-TOF MS could be
used to both identify an organism and determine whether
it is related to a previous clinical isolate (ie, perform
prospective epidemiology).
Although there are relatively few reports of MALDI-TOF
MS used for antimicrobial susceptibility testing, this is a
research area of exciting possibilities. Edwards-Jones et
al53 and Du et al54 reported distinct spectral profiles that
could be used to differentiate methicillin-susceptible and
methicillin-resistant Staphylococcus aureus. If these re-
sults are validated, then expression of methicillin resis-
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conventional test methods. Hrabak et al55 used MALDI-
TOF MS to assess meropenem degradation by carbap-
enemases. Although this test method would not replace
current methods, it could be used to confirm expression
of carbapenemase activity, a procedure that now re-
quires 1 to 2 days of additional testing. Rogers et al56
demonstrated that azole resistance in C. glabrata was
associated with differential expression of 25 proteins, and
Marinach et al57 compared the proteome of fluconazole-
susceptible strains of C. albicans with that of fluconazole-
resistant strains and demonstrated discrete profile
changes that corresponded to minimum inhibitory con-
centration values determined by the Clinical Laboratory
Standards Institute’s microdilution reference method. If
these results can be extended to additional clinical iso-
lates and other classes of antifungal drugs, then the
feasibility of rapid antifungal susceptibility testing is
promising.
Conclusions
MALDI-TOF MS offers the possibility of accurate, rapid,
and inexpensive identification of microorganisms. The
procedures for preanalysis processing of organisms and
analysis by MALDI-TOF MS are technically simple and
reproducible, and commercial databases and interpre-
tive algorithms are available for the identification of a
wide spectrum of bacteria, yeast, and mycobacteria. Ef-
forts by both users and manufacturers of commercial
systems to include less commonly isolated organisms in
the identification databases will further expand the utility
of MALDI-TOF MS. Although only limited work has been
reported on the use of mass spectrometry to identify
molds, perform strain typing, or determine antibiotic sus-
ceptibility results, these are fruitful areas of promising
research.
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